What is Fortrea Holdings Inc. (FTRE) stock price today?

Fortrea Holdings Inc. (FTRE) currently trades at $10.56 per share. The stock has a market capitalization of $998.82M and a P/E ratio of —x.

Is FTRE stock a buy, sell, or hold in 2026?

Based on WallStSmart's proprietary analysis, Fortrea Holdings Inc. has a Smart Value Score of 45/100 (Grade C), resulting in a "Sell" investment rating. The Piotroski F-Score is 3/9 and Altman Z-Score is 0.15.

What is Fortrea Holdings Inc.'s revenue and earnings?

Fortrea Holdings Inc. has trailing twelve-month (TTM) revenue of $2.72B with profit margins of -36.20%. Earnings per share (EPS) is $-10.81.

Is Fortrea Holdings Inc. financially healthy?

Fortrea Holdings Inc.'s Piotroski F-Score is 3/9 (weak financial health). The Altman Z-Score of 0.15 places it in the distress.

FTRE

Fortrea Holdings Inc.

NASDAQ: FTRE · HEALTHCARE · BIOTECHNOLOGY

$10.56

-1.86% today

Updated 2026-04-29

Market cap

$998.82M

P/E ratio

—

P/S ratio

0.37x

EPS (TTM)

$-10.81

Dividend yield

—

52W range

$4 – $19

Volume

1.5M

Market cap

$998.82M

P/E ratio

—

P/S ratio

0.37x

EPS (TTM)

$-10.81

Dividend yield

—

52W range

$4 – $19

Volume

1.5M

WallStSmart proprietary scores

out of 100

Grade: C

Sell

Investment rating

2.0

Growth

3.0

Quality

2.5

Profitability

6.7

Valuation

3/9

Piotroski F-Score

Weak

0.2

Altman Z-Score

Distress

—

Industry rank

—

View all highly rated stocks (75+) →200 stocks currently score above 75

Price targets

Analyst target

$12.66

+19.89%

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

1 Strong Buy5 Buy5 Hold0 Sell1 Strong Sell

Price chart

X-Ray snapshot

Strengths

+ Free cash flow $121.60M — positive

Risks

- Piotroski 3/9 — weak financial health

- Altman Z 0.15 — distress zone

- Thin margins at -36.20%

- Revenue declining -5.20% QoQ

- Debt/equity 2.04x — high leverage

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$2.84B	$2.84B	$2.70B	$2.72B	$2.72B
Net income	$186.20M	$-25.20M	$-328.50M	$-986.20M	$-32.50M
EPS	—	—	—	—	$-10.81
Free cash flow	$28.30M	$128.10M	$237.30M	$88.30M	$121.60M
Profit margin	6.56%	-0.89%	-12.18%	-36.21%	-36.20%

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
FTRE	$998.82M	45	2.0	2.5	6.7	3.0	—	Hold
LLY	$789.69B	78	10.0	10.0	5.0	6.5	—	Strong Buy
JNJ	$547.64B	59	4.7	9.0	3.3	6.0	-41.97%	Buy
ABBV	$351.47B	63	4.0	8.0	4.7	5.0	-24.92%	Buy
UNH	$322.34B	54	5.3	5.5	7.3	4.8	+42.06%	Buy
AZN	$294.17B	64	6.7	8.0	5.3	5.0	+4.07%	Buy

Smart narrative

Fortrea Holdings Inc. trades at $10.56. Our Smart Value Score of 45/100 indicates the stock is fair. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 0.15, it sits in the distress. TTM revenue stands at $2.72B. with profit margins at -36.20%.

Frequently asked questions

What is Fortrea Holdings Inc.'s stock price?

Fortrea Holdings Inc. (FTRE) trades at $10.56.

Is Fortrea Holdings Inc. overvalued?

Smart Value Score 45/100 (Grade C, Sell).

What is the price target of Fortrea Holdings Inc. (FTRE)?

The analyst target price is $12.66, representing +19.9% upside from the current price of $10.56.

What is Fortrea Holdings Inc.'s revenue?

TTM revenue is $2.72B.

Piotroski F-Score?

3/9 — weak financial health.

Altman Z-Score?

0.15 — distress.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

www.fortrea.com

Quick metrics

P/S ratio0.37x

ROE-102.40%

Beta1.78

50D MA$9.89

200D MA$11.09

Shares out0.09B

Float0.09B

Short ratio—

Avg volume1.5M

Performance

1 week+2.48%

1 month+21.31%

3 months-35.68%

YTD-37.62%

1 year—

3 years—

5 years—

Compare

FTRE vs LLY →FTRE vs JNJ →FTRE vs ABBV →Stock screener →